<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04617223</url>
  </required_header>
  <id_info>
    <org_study_id>34062/8/20</org_study_id>
    <nct_id>NCT04617223</nct_id>
  </id_info>
  <brief_title>Results of Endoscopic Sinus Surgery in Management of Ophthalmological Complications of Chronic Rhino Sinusitis</brief_title>
  <official_title>Results of Endoscopic Sinus Surgery in Management of Ophthalmological Complications of Chronic Rhino Sinusitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tanta University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tanta University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigate the clinical features of orbital complications of sinusitis in the Egyptian&#xD;
      population, and observed that certain ophthalmological manifestations and outcomes were&#xD;
      significantly associated with disease stage&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Retrospectively review of the medical records of all patients with orbital complications of&#xD;
      paranasal sinusitis hospitalized at the ORL-HNS department at the University of Tanta between&#xD;
      2010 and 2020. Sex, age, symptoms, history, ophthalmological findings, laboratory and imaging&#xD;
      findings, treatments, and outcomes were analyzed by staging.&#xD;
&#xD;
      The data that will be retrieved from the medical records including:&#xD;
&#xD;
        1. History taking including personal present and previous medical history.&#xD;
&#xD;
        2. General examination&#xD;
&#xD;
        3. Oto-rhinolaryngological clinical examination&#xD;
&#xD;
        4. Routine preoperative laboratory investigations (e.g. complete total and differential&#xD;
           blood count, blood sugar, coagulation profile, and renal and liver function)&#xD;
&#xD;
        5. Diagnostic nasal Endoscopy with zero and/or a 30-degree telescope.&#xD;
&#xD;
        6. CT paranasal sinuses with contrast, fine cuts in coronal axial, and sagittal planes.&#xD;
&#xD;
        7. The type of intervention whether medical or surgical. 8- Culture results, treatments,&#xD;
           hospital stay durations, and outcomes.&#xD;
&#xD;
      Ophthalmology data collection:&#xD;
&#xD;
        1. Visual acuity (onset of decrease) (unilateral or bilateral) ant its improvement after&#xD;
           sinus surgery&#xD;
&#xD;
        2. Presence or absence of double vision (Diplopia)&#xD;
&#xD;
        3. Ocular motility and if its associated with pain&#xD;
&#xD;
        4. Proptosis (present or absent) and calculate the degree and direction&#xD;
&#xD;
        5. Ptosis (present or absent)&#xD;
&#xD;
        6. Pupil reactivity&#xD;
&#xD;
        7. Fundus examination to exclude optic nerve neuropathy&#xD;
&#xD;
        8. Association between ocular pain and headache and its improvement after surgery&#xD;
&#xD;
        9. CT data collection (CT orbit, MRI of sinus and head)&#xD;
&#xD;
       10. Fundus photography after surgery to see improvement of optic nerve neuropathy if present&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 13, 2021</start_date>
  <completion_date type="Actual">September 1, 2021</completion_date>
  <primary_completion_date type="Actual">July 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>observe improvement of ophthalmological manifestation after surgical intervention</measure>
    <time_frame>1 month</time_frame>
    <description>Measure the visual acuity by using Snellen chart and LogMAR chart (Logarithm of the minimum angle of resolution ) chart&#xD;
The Minimum number of snellen chart is 6/60 and maximum number is 6/6, The Minimum number of LogMAR chart is 1.0 and maximum number is - 0.1, The higher number means better vision</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Improvement of the degree of proptosis after surgery</measure>
    <time_frame>1 month</time_frame>
    <description>Decrease the degree of proptosis in millimeter</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">64</enrollment>
  <condition>Chronic Sinusitis</condition>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endoscopic sinus evacuation</intervention_name>
    <description>Evacuation of the sinus by using endoscope</description>
    <arm_group_label>Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient presented with preseptal/orbital inflammation secondary to acute (&lt;1 month),&#xD;
             subacute (1±3 months), or chronic sinusitis (&gt;3 months) of bacterial, fungal or&#xD;
             unidentified pathogens&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with chronic rhinosinusitis without orbital complication, Systemic diseases&#xD;
             that affect the paranasal sinuses and the orbit e.g autoimmune diseases, lymphoma,&#xD;
             leukaemia, Sinus or orbital malignancy, Data is missed from the charts&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Tanta University Hospital</name>
      <address>
        <city>Tanta</city>
        <state>El-Garbeia</state>
        <zip>31515</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <results_reference>
    <citation>Hastan D, Fokkens WJ, Bachert C, Newson RB, Bislimovska J, Bockelbrink A, Bousquet PJ, Brozek G, Bruno A, Dahlén SE, Forsberg B, Gunnbjörnsdóttir M, Kasper L, Krämer U, Kowalski ML, Lange B, Lundbäck B, Salagean E, Todo-Bom A, Tomassen P, Toskala E, van Drunen CM, Bousquet J, Zuberbier T, Jarvis D, Burney P. Chronic rhinosinusitis in Europe--an underestimated disease. A GA²LEN study. Allergy. 2011 Sep;66(9):1216-23. doi: 10.1111/j.1398-9995.2011.02646.x. Epub 2011 May 24.</citation>
    <PMID>21605125</PMID>
  </results_reference>
  <results_reference>
    <citation>Shi JB, Fu QL, Zhang H, Cheng L, Wang YJ, Zhu DD, Lv W, Liu SX, Li PZ, Ou CQ, Xu G. Epidemiology of chronic rhinosinusitis: results from a cross-sectional survey in seven Chinese cities. Allergy. 2015 May;70(5):533-9. doi: 10.1111/all.12577. Epub 2015 Mar 4.</citation>
    <PMID>25631304</PMID>
  </results_reference>
  <results_reference>
    <citation>Chang YS, Chen PL, Hung JH, Chen HY, Lai CC, Ou CY, Chang CM, Wang CK, Cheng HC, Tseng SH. Orbital complications of paranasal sinusitis in Taiwan, 1988 through 2015: Acute ophthalmological manifestations, diagnosis, and management. PLoS One. 2017 Oct 3;12(10):e0184477. doi: 10.1371/journal.pone.0184477. eCollection 2017.</citation>
    <PMID>28972988</PMID>
  </results_reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>October 13, 2020</study_first_submitted>
  <study_first_submitted_qc>October 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 5, 2020</study_first_posted>
  <last_update_submitted>September 16, 2021</last_update_submitted>
  <last_update_submitted_qc>September 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tanta University</investigator_affiliation>
    <investigator_full_name>Dina Tadros</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sinusitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>3 month</ipd_time_frame>
    <ipd_access_criteria>link</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

